Zivaflibercept works by changing the amount of blood that gets to the tumor. Drugs administered other than oral method, chemotherapy drugs. As of 20, this field contains the consumer friendly descriptions for the ama cpt codes. Aflibercept, a human prescription drug labeled by regeneron pharmaceuticals, inc. Comparison of aflibercept, bevacizumab, and ranibizumab. J9400 hcpcs code for injection, zivaflibercept, 1 mg. Aflibercept is a recombinant fusion protein that acts as a soluble decoy receptor and binds to vascular endothelial growth factors a and b vegfa, vegfb and placental growth factor plgf. Aflibercept was first approved in 2011 for the treatment of neovascular wet agerelated macular edema. The use of na indicates that the hcpcs code was not available. Before you receive an aflibercept injection, your doctor will clean your eye to prevent infection and numb your eye to. This comprehensive report is communicated by fax or via the eylea4u eportal within 2 business days of enrollment submission. C9296 injection, zivaflibercept, 1 mg the above description is abbreviated.
The ndc code 6175500502 is assigned to eylea also known as. Colorectal cancer that has metastasized spread to other parts of the body. Na may mean that a the hcpcs code has not yet been created new drug, b the drug is given as an oral drug or alternative route only in specific instances are hcpcs assigned to these medications, or c the hcpcs could not be found or is truly not available. See also cpb 0701 vascular endothelial growth factor inhibitors for ocular. It is indicated for the treatment of patients with neovascular wet agerelated macular degeneration amd. Retina today will a new lowcost option join the anti. Zivaflibercept intravenous route description and brand. In addition to commercially available aflibercept, two other drugs, zivaflibercept and conbercept, have been studied in antiangiogenic. Aflibercept injection is also used to treat macular edema after retinal vein occlusion. It is used in patients who have already been treated with other cancer medicines that did not work well. Aflibercept must be billed on the same claim as the drug, with cpt code 67028 intravitreal injection of a pharmacologic agent. Zivaflibercept is usually given once every 14 days. Free zivaflibercept concentrations appear to exhibit linear pharmacokinetics in the dose range of 2 mg per kg to 9 mg per kg.
Aflibercept injection is used to treat neovascular wet agerelated macular degeneration. This code description may also have includes, excludes, notes, guidelines, examples and other information. Aflibercept injection advanced patient information. Antivegf medicines aflibercept and ranibizumab would have to drop in price by 69% and 80%, respectively, to be worth the societal cost compared with bevacizumab, a new study has found. It works by keeping new blood vessels from forming in a fastgrowing tumor. Amd is a disorder of the retina in the eye that causes blurred vision or blindness. Your doctor will give you injections on a schedule that is best for you and your condition. Zivaflibercept acts as a decoy by binding to vegfa,b and plgf and stops their activation, inhibiting tumor growth. Srp provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable populationbased statistics. Hcpcs code j9400 for injection, zivaflibercept, 1 mg. Call your doctor at once if you have eye pain or redness, swelling or puffiness around your eyes, or sudden vision problems at any time during treatment. Retina today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma.
It is also used to treat diabetic macular edema dme. You should not use eylea if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in eylea, including aflibercept. Aflibercept, an intravenously administered antivegf and antiplacental growth factor plgf agent, has recently been approved by the u. Vascular endothelial growth factor vegf inhibitor therapeutic class. In transmittal 2450 to macs and mm7854 for providers and other suppliers, q2046 is described as injection, aflibercept, 1 mg the new hcpcs code is effective n july 1, 2012. J0178 is a valid 2020 hcpcs code for injection, aflibercept, 1 mg or just aflibercept injection for short, used in medical care. Medicine used in the eyes is not likely to be affected by other drugs you use. Fda approval of aflibercept for wet amd gives clinicians, patients another option while some retina specialists question the drugs ability to extend the treatment interval, most are happy to. J9400 injection, zivaflibercept, 1 mg the above description is abbreviated. What other drugs will affect aflibercept ophthalmic eylea, eylea prefilled syringe. Persons with disabilities having problems accessing the pdf files below may call 301 7963634 for assistance. Your doctor may need to delay your treatment or adjust your dose if you experience certain side effects. Aflibercept injection is used to treat neovascular wet agerelated macular degeneration amd.
Zivaflibercept is approved to be used with folfiri to treat. This is the 20 version of hcpcs j0178 please refer to the 2016 hcpcs code set for the latest version status. Eylea4u support includes a thorough bi thatwithin 2 business dayssummarizes your patients coverage, pa requirements, cost responsibility, and any additional coverage information. Aflibercept is a recombinant fusion protein consisting of portions of human vegf receptors 1 and 2 extracellular domains fused to the fc portion of human igg1 formulated as an. Seer is supported by the surveillance research program srp in ncis division of cancer control and population sciences dccps. J0178 injection, aflibercept, 1 mg the above description is abbreviated. Aflibercept solution for injection for treating wet age. Newsletters, articles, podcasts, videos, calculators and more. J9400 is a valid 2019 hcpcs code for injection, zivaflibercept, 1 mg or just inj, zivaflibercept, 1mg for short, used in medical care. Fda approval of aflibercept for wet amd gives clinicians. It was developed by regeneron pharmaceuticals and is approved in the united states and europe it is an inhibitor of vascular endothelial growth factor vegf. Zaltrap zivaflibercept is indicated in combination with 5fluorouracil, leucovorin, irinotecanfolfiri for patients with metastatic colorectal cancer mcrc that is resistant to or has progressed following an oxaliplatincontaining regimen. In some cases, health care professionals may use the trade name zaltrap when referring to the generic drug name zivaflibercept. The recommended dosage of zivaflibercept zaltrap is 4 mgkg body weight as an intravenous infusion every 2 weeks.
Effective for dates of service 11182011 and after, the appropriate site modifier rt, lt or 50 must be appended to cpt code 67028 to indicate if. Aflibercept inhibits the activation of vegf receptors and the proliferation of endothelial cells, thereby inhibiting the growth of new vessels. You should not use aflibercept if you have swelling inside your eyes, or any type of infection in or around your eyes. Find patient medical information for aflibercept intravitreal on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Aflibercept injection eylea is a recombinant fusion protein consisting of portions of human vegf receptors 1 and 2 extracellular domains fused to the fc portion of human igg1 formulated as an isoosmotic solution for intravitreal administration. Zivaflibercept is also being studied in the treatment of other types of cancer. In a recent public notice, the centers for medicare and medicaid cms noted that a new hcpcs code, q2046, will be in effect. Aflibercept definition of aflibercept by medical dictionary. Zaltrap zivaflibercept is a prescription anticancer medicine used in combination with the chemotherapy regimen 5fluorouracil, leucovorin, and irinotecanfolfiri to treat metastatic colorectal cancer that has progressed during or after treatment with other anticancer medicines that include oxaliplatin. Worse visual acuity when initiating therapy was associated with greater visual acuity benefit of aflibercept over bevacizumab or ranibizumab 1 year later. Eylea aflibercept gets new hcpcs supply code corcoran.
More recently, a different class of drugs, fusion proteins, has provided an alternative treatment strategy with pharmacological differences. In the last few years, monoclonal antibodies have revolutionized the treatment of retinal neovascular diseases. Zivaflibercept is used in combination with other medications to. Zivaflibercept injection come as a solution to be injected intravenously into a vein over at least 1 hour by a doctor or nurse in a medical facility. Aflibercept is an approved therapy for neovascular agerelated macular degeneration amd and diabetic macular oedema dme.
Tell each of your healthcare providers about all medicines you use, including prescription and overthecounter medicines, vitamins. On average, all 3 antivegf agents led to improved visual acuity in eyes with dme involving the center of the retina and visual acuity impairment. Each issue provides insight from wellrespected specialists on cuttingedge therapies and surgical techniques that are. Zaltrap is a vascular endothelial growth factor vegf inhibitorintravenous formulation. Steady state concentrations of free zivaflibercept were reached by the second dose. Aflibercept, aflibercept supplier, aflibercept distributor, cas 8621128, aflibercept manufacturer, aflibercept wholesale. The accumulation ratio for free zivaflibercept was approximately 1.
Zivaflibercept formerly known as aflibercept, vegf trap is a recombinant fusion protein. Two phase iii trials showed the aflibercept was not inferior to ranibizumab in maintaining visual acuity at 52 weeks. Use zivaflibercept during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. It is used in patients whose disease has not gotten better with other chemotherapy. Zivaflibercept is made from a human antibody fragment. Zivaflibercept injection is given together with other medicines eg, fluorouracil, irinotecan, leucovorin to treat advanced cancer of the colon or rectum.
972 586 1369 898 1120 548 859 850 453 1317 473 1287 511 185 96 1388 265 1523 703 1252 1491 735 1081 661 449 511 26 1035 1330 280 1015 768 78 271 494 572 1135